cannabosides

January 11, 2018

Vitality Biopharma Unveils Cannabis-based Potential Bowel Disease Therapy

News

Vitality Biopharma has developed a cannabis-based potential treatment for inflammatory bowel diseases. Its annoucement about VITA-100 comes as U.S. regulators have been approving cannabis-based products for various disorders. VITA-100 delivers two of the active ... Read more

July 21, 2017August 18, 2017

Cannabosides Show Positive Results as Potential Colitis Treatment in Preclinical Studies

News, Ulcerative colitis

A new class of ingestible cannabinoid prodrugs known as cannabosides developed to treat colitis have shown positive results in preclinical studies, Vitality Biopharma has announced. Cannabosides are a modification of a novel class ... Read more

April 13, 2017

Vitality Biopharma Appoints Regulatory Advisor for Cannabis-Derived Prodrugs Program

News

Vitality Biopharma has appointed Tracy Rockney, co-founder and chief operating officer at OneSource Regulatory, to the position of senior regulatory advisor. She will be responsible for the regulatory development of ... Read more

August 8, 2016August 8, 2016

Vitality Biopharma Developing Cannabis-derived Prodrugs for Inflammatory Bowel Disease

News

Vitality Biopharma of California has developed a new class of cannabis-derived cannabinoid prodrugs, known as cannabosides, which can enable the selective delivery of cannabidiol (CBD), a cannabinoid compound, to the intestinal tract, ... Read more